Yoshajandith Aguirre-Vidal

Yoshajandith Aguirre-Vidal

Auto-generated profile, based on publicly available information

Yoshajandith Aguirre-Vidal

Laboratorio de Neuroprotección, Facultad de Farmacia, Universidad Autónoma Del Estado de Morelos, Cuernavaca, Morelos, Mexico

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Steroids
Verified
Journal Article
Closed access
YAYoshajandith Aguirre-Vidal
Yoshajandith Aguirre-Vidal
AMAntonio Monroy-Noyola
Antonio Monroy-Noyola
LALaura Anaya-Ramos
Laura Anaya-Ramos
MAMarcela Arteaga-Silva
Marcela Arteaga-Silva
MMMarisela Mendez-Armenta
Marisela Mendez-Armenta
SMSergio Montes
Sergio Montes

1 May 2015 in NeuroToxicology
Verified
Journal Article
Closed access
YAYoshajandith Aguirre-Vidal
Yoshajandith Aguirre-Vidal
SMSergio Montes
Sergio Montes
LTLUIS TRISTÁN-LÓPEZ
LUIS TRISTÁN-LÓPEZ
LALaura Anaya-Ramos
Laura Anaya-Ramos
JTJohn Teiber
John Teiber
AMAntonio Monroy-Noyola
Antonio Monroy-Noyola

15 October 2019 in Journal of Chemistry
Verified
Journal Article
Open access
PDF file
AGAbraham Gutierréz-Hernández
Abraham Gutierréz-Hernández
YGYelzyn Galván-Ciprés
Yelzyn Galván-Ciprés
EDElix Alberto Domínguez-Mendoza
Elix Alberto Domínguez-Mendoza
YAYoshajandith Aguirre-Vidal
Yoshajandith Aguirre-Vidal
SESamuel Estrada-Soto
Samuel Estrada-Soto
Gabriel Navarrete-VazquezGabriel Navarrete-Vazquez
Gabriel Navarrete-Vazquez
A simple and cheap three-step procedure for the synthesis of three (5Z)-5-[3(4)-(1H-benzimidazol-2-ylmethoxy)benzylidene]-1,3-thiazolidine-2,4-diones has been described via a SN2 reaction of generally recognized as safe hydroxybenzaldehydes and 2-(chloromethyl)-1H-benzimidazole, followed by a Knoevenagel condensation with thiazolidine-2,4-dione in moderated yields. All the newly synthesized compounds were characterized using analytical and spectral studies. In vitro treatment on adipocytes with compounds increased the mRNA expression of two proteins recognized as strategic targets in diabetes: PPARγ and GLUT-4. In silico studies were conducted in order to explain the interaction binding mode of the synthesized compounds on PPARγ. In vivo studies confirmed that compounds 1–3 have robust antihyperglycemic action linked to insulin sensitization mechanisms. The present study provides three compounds with a promising antidiabetic action.

8 December 2025
Verified
Book Chapter
Closed access
GABRIELA ÁVILA-VILLARREALGABRIELA ÁVILA-VILLARREAL
GABRIELA ÁVILA-VILLARREAL
BVBrisia Marlen Ortiz Vargas
Brisia Marlen Ortiz Vargas
Guadalupe Yáñez-IbarraGuadalupe Yáñez-Ibarra
Guadalupe Yáñez-Ibarra
MMMartha Edith Cancino Marentes
Martha Edith Cancino Marentes
YVYoshajandith Aguirre Vidal
Yoshajandith Aguirre Vidal